ATE298788T1 - Verfahren zur herstellung von infektiösen reoviren - Google Patents

Verfahren zur herstellung von infektiösen reoviren

Info

Publication number: ATE298788T1
Authority: AT; Austria
Prior art keywords: reoviruses; producing infectious; infectious; producing; infectious reoviruses
Prior art date: 2000-08-10

Application number

AT01953084T

Other languages

English (en)

Inventor

Matthew C Coffey

Bradley G Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-20

Publication date

2005-07-15

2001-07-20 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2005-07-15 Application granted granted Critical

2005-07-15 Publication of ATE298788T1 publication Critical patent/ATE298788T1/de

Links

241000702244 Orthoreovirus Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000002458 infectious effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT01953084T 2000-08-10 2001-07-20 Verfahren zur herstellung von infektiösen reoviren ATE298788T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22402600P	2000-08-10	2000-08-10
PCT/CA2001/001054 WO2002012435A1 (en)	2000-08-10	2001-07-20	Method of producing infectious reovirus

Publications (1)

Publication Number	Publication Date
ATE298788T1 true ATE298788T1 (de)	2005-07-15

Family

ID=22838987

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT01953084T ATE298788T1 (de)	2000-08-10	2001-07-20	Verfahren zur herstellung von infektiösen reoviren
AT05009952T ATE394475T1 (de)	2000-08-10	2001-07-20	Methode zur herstellung von infektiösem reovirus

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT05009952T ATE394475T1 (de)	2000-08-10	2001-07-20	Methode zur herstellung von infektiösem reovirus

Country Status (18)

Country	Link
US (4)	US6528305B2 (de)
EP (2)	EP1586634B1 (de)
JP (2)	JP4009532B2 (de)
AR (1)	AR033993A1 (de)
AT (2)	ATE298788T1 (de)
AU (2)	AU2001275628B2 (de)
BR (1)	BR0113122A (de)
CA (1)	CA2415749C (de)
DE (2)	DE60111747T2 (de)
DK (2)	DK1586634T3 (de)
ES (2)	ES2305940T3 (de)
IL (2)	IL153847A0 (de)
MX (1)	MXPA03000846A (de)
NZ (1)	NZ523510A (de)
PT (2)	PT1586634E (de)
TW (1)	TWI289158B (de)
WO (1)	WO2002012435A1 (de)
ZA (1)	ZA200300410B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545492B1 (en) *	1999-09-20	2003-04-08	Europaisches Laboratorium Fur Molekularbiologie (Embl)	Multiple local probe measuring device and method
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus
IL157304A0 (en)	2001-03-16	2004-02-19	Oncolytics Biotech Inc	Method of extracting virus from cell culture
US20040115170A1 (en) *	2001-11-30	2004-06-17	Brown Earl Garnet	Oncolytic virus
US20040005546A1 (en)	2002-02-28	2004-01-08	Oncolytics Biotech Inc.	Use of ribozymes in the detection of adventitious agents
CA2374388C (en)	2002-02-28	2005-07-12	Matthew C. Coffey	The use of ribozymes in the detection of adventitious agents
ATE348153T1 (de) *	2002-04-29	2007-01-15	Univ Pennsylvania	Methode für die direkte gewinnung und amplifikation von integrierten viren aus zellulärer gewebe-dna
DE60327069D1 (de)	2002-04-30	2009-05-20	Oncolytics Biotech Inc	Verbesserte reinigungsmethode für viren
JP5241059B2 (ja) *	2002-05-09	2013-07-17	オンコリティクスバイオテク，インコーポレーテッド	腫瘍崩壊ウイルスを使用して疼痛を軽減するための方法
EP1944035A1 (de)	2002-05-09	2008-07-16	Oncolytics Biotech Inc.	Verfahren zur Schmerzlinderung durch onkolytische Viren
AU2003229180B8 (en) *	2002-05-10	2009-07-02	Oncolytics Biotech Inc.	Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US7490608B2 (en) *	2005-06-17	2009-02-17	Nellcorr Puritan Bennett Llc	System and method for adjusting a gas delivery mask
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
US10260049B2 (en)	2005-08-01	2019-04-16	Virocure, Inc.	Attenuated reovirus
ES2551306T3 (es) *	2006-02-13	2015-11-17	Oncolytics Biotech Inc.	Uso de inmunosupresión local de baja dosis para potenciar una terapia viral oncolítica
US8293498B2 (en)	2006-12-20	2012-10-23	Vanderbilt University	System for generation of viable reovirus from cloned cDNA
WO2008127486A2 (en) *	2006-12-29	2008-10-23	Bacilligen, Inc.	Replication-proficient dsrna capsids and uses thereof
SG191602A1 (en) *	2007-03-12	2013-07-31	Oncolytics Biotech Inc	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
TW200909581A (en) *	2007-05-21	2009-03-01	Oncolytics Biotech Inc	Mutant reoviruses and methods of making and using
JP2011500608A (ja) *	2007-10-22	2011-01-06	オンコリティクスバイオテク，インコーポレーテッド	増殖性障害の治療レジメン
WO2009143611A1 (en) *	2008-05-27	2009-12-03	Oncolytics Biotech Inc.	Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
EP2296678A4 (de) *	2008-05-27	2012-03-21	Oncolytics Biotech Inc	Modulation des interstitiellen drucks sowie onkolytische virenfreisetzung und -verteilung
WO2011126976A1 (en)	2010-04-07	2011-10-13	Vanderbilt University	Reovirus vaccines and methods of use therefor
BR112012026095A2 (pt)	2010-04-14	2015-09-15	Emd Millipore Corp	métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
EP2646051A4 (de)	2010-12-02	2014-05-28	Oncolytics Biotech Inc	Flüssige virale formulierungen
MX349294B (es)	2010-12-02	2017-07-21	Oncolytics Biotech Inc	Formulaciones virales liofilizadas.
DK3068411T3 (da)	2013-11-15	2020-06-22	Oncolytics Biotech Inc	Oncolytiske vira og forøget cancerbehandlingsregimer
CN112143693B (zh) *	2019-06-28	2024-12-27	杭州康万达医药科技有限公司	一种生产病毒的方法及收获液组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070453A (en) *	1976-06-25	1978-01-24	Syntex (U.S.A.) Inc.	Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) *	1982-07-20	1985-12-17	Research Foundation	Avian proventriculitis vaccine
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5658779A (en)	1992-03-20	1997-08-19	Ligochem, Inc.	Method of adsorbing viruses from fluid compositions
JPH08214876A (ja)	1995-02-15	1996-08-27	Chemo Sero Therapeut Res Inst	ウイルスの調製法
WO1998022588A2 (en)	1996-11-20	1998-05-28	Introgen Therapeutics, Inc.	An improved method for the production and purification of adenoviral vectors
AU8437998A (en)	1997-06-24	1999-01-04	Basf Aktiengesellschaft	Method for producing 4,4' dihalogendiphenylsulfone
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
US6136307A (en)	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
AR028039A1 (es)	2000-05-03	2003-04-23	Oncolytics Biotech Inc	Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/de not_active Expired - Lifetime
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 EP EP01953084A patent/EP1309672B1/de not_active Expired - Lifetime
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en not_active Ceased
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
2003
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
DE60111747T2 (de)	2006-04-27
AR033993A1 (es)	2004-01-21
EP1586634A1 (de)	2005-10-19
ATE394475T1 (de)	2008-05-15
CA2415749C (en)	2009-05-12
IL153847A0 (en)	2003-07-31
US20040126869A1 (en)	2004-07-01
TWI289158B (en)	2007-11-01
DE60111747D1 (de)	2005-08-04
US6528305B2 (en)	2003-03-04
US20030166253A1 (en)	2003-09-04
US20060165724A1 (en)	2006-07-27
BR0113122A (pt)	2003-07-22
PT1586634E (pt)	2008-06-19
DE60133947D1 (de)	2008-06-19
ZA200300410B (en)	2004-01-26
US7429485B2 (en)	2008-09-30
MXPA03000846A (es)	2004-04-05
AU2001275628B2 (en)	2007-08-30
PT1309672E (pt)	2005-09-30
EP1309672A1 (de)	2003-05-14
EP1309672B1 (de)	2005-06-29
AU7562801A (en)	2002-02-18
JP4009532B2 (ja)	2007-11-14
CA2415749A1 (en)	2002-02-14
US6703232B2 (en)	2004-03-09
EP1586634B1 (de)	2008-05-07
JP2006314336A (ja)	2006-11-24
NZ523510A (en)	2004-08-27
JP2004505623A (ja)	2004-02-26
HK1082765A1 (en)	2006-06-16
US20020037576A1 (en)	2002-03-28
DK1586634T3 (da)	2008-08-18
ES2241844T3 (es)	2005-11-01
WO2002012435A1 (en)	2002-02-14
IL153847A (en)	2007-10-31
ES2305940T3 (es)	2008-11-01
DK1309672T3 (da)	2005-10-10
US7049127B2 (en)	2006-05-23
AU2001275628B8 (en)	2002-02-18

Legal Events

Date

Code

Title

Description

2006-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1309672

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE298788T1 (de)	2005-07-15	Verfahren zur herstellung von infektiösen reoviren
ATE386736T1 (de)	2008-03-15	Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
DE60107450D1 (de)	2004-12-30	Verfahren zur herstellung von fluoroelastomeren
DE60123615D1 (de)	2006-11-16	Verfahren zur herstellung von ultrahochreinem isopropanol
DE60144508D1 (de)	2011-06-09	Verfahren zur Herstellung von Proben
AT7110U9 (de)	2004-11-25	Verfahren zur herstellung von amlodipinmaleat
DE60221399D1 (de)	2007-09-06	Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de)	2008-08-15	Verfahren zur herstellung von o- desmethylvenlafaxin
DE50006193D1 (de)	2004-05-27	Verfahren zur herstellung von otoplastiken und otoplastik
ATE281448T1 (de)	2004-11-15	Verfahren zur herstellung von citalopram
DE50103033D1 (de)	2004-09-02	Verfahren zur herstellung von borstenwaren
DE60230908D1 (de)	2009-03-05	Verfahren zur herstellung von polyarylenethern
DE60133118D1 (de)	2008-04-17	Verfahren zur herstellung von oberflächenelementen
DE60126336D1 (de)	2007-03-15	Verfahren zur herstellung von hochreinen durchscheinenden perfluorelastomer-gegenständen
ATE331804T1 (de)	2006-07-15	Verfahren zur herstellung von ansamitocin
ATE328885T1 (de)	2006-06-15	Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen
DE50102444D1 (de)	2004-07-01	Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de)	2006-02-15	Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
ATE266004T1 (de)	2004-05-15	Verfahren zur herstellung von 3-amino-2-chlor-4- methylpyridin
DE50111560D1 (de)	2007-01-11	Verfahren zur herstellung von guerbetalkoholen
ATE389645T1 (de)	2008-04-15	Verfahren zur herstellung von citalopram
ATE272626T1 (de)	2004-08-15	Verfahren zur herstellung von pyrazolopyrimidinonen
DE60134415D1 (de)	2008-07-24	Verfahren zur herstellung von wäscheweichmacherzusammensetzungen
DE50200870D1 (de)	2004-09-23	Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60105991D1 (de)	2004-11-04	Verfahren zur herstellung von 6-aminocapronamid